guanabenz
Ligand Summary
An alpha-2 selective adrenergic agonist used as an antihypertensive agent.
UNII: GGD30112WC
PubChem: 5702063
Guide to Pharmacology: 5443
ChEMBL: CHEMBL420
DrugCentral: 3952
LyCHI: DLJGCQBZ9NJB
Target Activities
ADRA2A
Alpha-2A adrenergic receptor
4 Activities
Items per page:
1 – 4 of 4
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
IC50 | 7.4 | |||||
Ki | 7.82 | None, None:None:None | ||||
IC50 | 7.39 | None, None:None:None | ||||
Ki | 7.82 | AGONIST | ||||
ADRA2B
Alpha-2B adrenergic receptor
3 Activities
Items per page:
1 – 3 of 3
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
IC50 | 6.8 | |||||
Ki | 7.17 | None, None:None:None | ||||
Ki | 7.17 | AGONIST | ||||
ADRA2C
Alpha-2C adrenergic receptor
2 Activities
Items per page:
1 – 2 of 2
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
IC50 | 5.96 | |||||
Ki | 6.79 | AGONIST | ||||
HTR2B
5-hydroxytryptamine receptor 2B
2 Activities
Items per page:
1 – 2 of 2
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
Ki | 7.21 | None, None:None:None | ||||
IC50 | 7.01 | None, None:None:None | ||||
NISCH
Nischarin
2 Activities
TAAR1
Trace amine-associated receptor 1
1 Activities
Items per page:
1 – 1 of 1
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
EC50 | 7.05 | MedChemComm, (2015) 6:12:2216 | ||||